mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
8e-05 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
9e-05 |